Bone Marrow Pathology Group

Daniel Arber, MD
Daniel Arber is the Donald West and Mary Elizabeth King Professor and Chair of the Department of Pathology at the University of Chicago. Prior to moving to Chicago in 2016, he was the Ronald F. Dorfman Professor of Hematopathology at Stanford University and Vice Chair of Pathology for Clinical Services. He has authored over 300 original articles and book chapters in hematopathology and molecular diagnostics. His research interests include the evaluation of prognostic and diagnostic markers in acute myeloid leukemia. He was a senior advisor for the 2016 revision to the World Health Organization classification of hematopoietic and lymphoid neoplasms and co-chaired a combined College of American Pathologist/American Society for Hematology initiative to develop guidelines for the work up of acute leukemia patients.

Adam Bagg, MD
Adam Bagg attended Medical School at the University of the Witwatersrand in South Africa, where he also completed his Pathology training in Laboratory Hematology /Hematopathology. He spent a decade at Georgetown University in Washington DC, where he repeated residency/fellowship training and subsequently joined the faculty, ultimately as Director of Hematopathology. Currently, Dr. Bagg is a Professor of Pathology and Laboratory Medicine at the University of Pennsylvania, where he is Director of Hematology, and the Hematopathology Laboratory. For the past 11 years (2010-2020), he was voted by his peers as one of Philadelphia’s “Top Doctors” (as the only hematopathologist so noted). He was elected to Council/Board of Directors of USCAP for a 4-year term in 2011. Dr. Bagg has lectured extensively nationally (including at USCAP, ASCP, AMP, CAP, ACLPS, AACC, ISLH and ASH) and internationally (21 countries). He has over 200 publications, including peer-reviewed articles, invited reviews and textbook chapters, most in the realm of the molecular pathology of hematologic malignancies. He is an Associate Editor (for Hematopathology) of the Journal of Molecular Diagnostics and on the Editorial Board of Advances in Anatomic Pathology.

Carlos Bueso-Ramos, MD, PhD
Dr. Carlos Bueso-Ramos is a Professor in the Department of Hematopathology and Section Chief of the Diagnostic Bone Marrow Laboratory at The University of Texas MD Anderson Cancer Center, where he also serves as a Faculty member in the Diagnostic Genetics Program at the UT School of Health Professions. He received his MD from the Universidad Autonoma in Honduras and his PhD from Emory University School of Medicine, where he also completed his AP/CP Residency Training as well. He completed his Surgical Pathology and Hematopathology training at MD Anderson Cancer Center. Dr. Bueso-Ramos served as a Member of the Clinical Advisory Committee for the Revision to the 4th edition of the WHO Classification of Haematopoietic and Lymphoid Neoplasms. His interests include apoptosis and proliferation in leukemias and factors that affect the regulation of cell lineage determination, maturation arrest and transformation in leukemia. His current studies focus on hematopoietic cytokines and DNA binding proteins that regulate the NF-kB and p53 pathways.

Kathy Foucar, MD
Dr. Foucar received her BS and MD degrees from Ohio State University, Columbus, Ohio, and her specialty training in AP/CP at the University of New Mexico and the University of Minnesota. She completed a surgical pathology fellowship at the University of Minnesota. She has over 40 years of practice in diagnostic hematopathology, and is the co-founder of the Hematopathology Fellowship at UNM. She is a Distinguished Professor of Pathology Emerita at the University of New Mexico Health Sciences Center. She is the author/co-author or editor of thirteen books on neoplastic and non-neoplastic hematopathology with an emphasis on blood and bone marrow, and over 120 peer-reviewed publications. She is the 2019 recipient of the Alumni Achievement Award from Ohio State University School of Medicine.

Tracy I. George, MD
Dr. Tracy George is Chief Medical Officer at ARUP Laboratories and Professor of Pathology at the University of Utah. Prior to moving to Utah in 2018, Dr. George was Vice Chair of Clinical Affairs, Hematopathology Division Chief, and the Hematopathology Fellowship Director at the University of New Mexico. Dr. George received her medical degree from the University of California San Francisco School of Medicine, where she completed a residency in Pathology and Laboratory Medicine. She completed her specialty training in Hematopathology and Surgical Pathology at Stanford University School of Medicine, where she was also a faculty member for a decade. Dr. George is President for the International Society for Laboratory Hematology (ISLH) and previously served as Editor-in-Chief for the International Journal of Laboratory Hematology. She has authored more than 130 peer reviewed publications, and lectured around the world at various conferences including the American Society of Hematology, the College of American Pathologists (CAP), the European Competence Network on Mastocytosis, the United States and Canadian Academy of Pathology, and ISLH. Her research interests are in laboratory hematology and the pathology of myeloid neoplasms, specifically mast cell disease. Dr. George received the CAP Lifetime Achievement Award in 2014./p>

Robert Hasserjian, MD
Dr. Robert Hasserjian is a Professor of Pathology at Massachusetts General Hospital and Harvard Medical School, where he is Director of the Hematopathology Fellowship and is an Associate Director of the Pathology Residency Program. Dr Hasserjian received his MD from Harvard in 1990 and trained in Anatomic Pathology and Hematopathology at Brigham and Women's Hospital. Dr Hasserjian is a Senior Reviewer for the update to the 4th edition of the WHO Classification of Myeloid Neoplasms and is currently the Secretary/Treasurer of the Society for Hematopathology. His research interests are in the discovery of pathologic and genetic features associated with the biologic behavior of myeloid and lymphoid neoplasms.

Eric Hsi, MD
Eric Hsi, is a Professor of Pathology and Chair of the Department of Pathology at Wake Forest School of Medicine. Dr. Hsi received his MD degree and did his AP/CP and hematopathology training at the University of Michigan. He is an expert in diagnosis and classification of hematologic malignancy with interests in immunophenotyping and molecular hematopathology. His research interests include pre-clinical therapeutic assessment and biomarkers in lymphoma and leukemia. He has authored over 350 peer-reviewed manuscripts, edited a textbook in Hematopathology, serves on several editorial boards, and has held committee leadership positions for the College of American Pathologists, ALLIANCE, and American Society for Hematology.

Attilio Orazi, MD
Attilio Orazi M.D., FRCPath. (Engl.) is Tenured Professor and Chair of the Department of Pathology at Texas Tech Health Sciences Center El Paso, Texas. He has published more than 270 articles and more than 30 book chapters. He is first, lead or co-author of four textbooks: Knowles’ Neoplastic Hematopathology; Illustrated Pathology of the Bone Marrow; Benign and Reactive Conditions of Lymph Node and Spleen; and Disorders of the Spleen. He was a Senior Advisor for the 2016 update of the 4th edition of the WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues. He is a member of several editorial boards. His research interests include diagnostic integration and prognostic assessment in bone marrow and spleen pathology.

Joyce Heesun Rogers, MD, PhD
Dr. Rogers received her MD in Ewha Womans University and PhD in Chung-Ang University, Seoul, South Korea. After her post-doctoral fellowship in Case Western Reserve University, Cleveland, OH, she completed a residency in Anatomic Pathology and Laboratory Medicine at the MetroHealth Medical Center affiliated with Case Western Reserve University and a subspecialty training in Hematopathology in Cleveland Clinic, Cleveland, OH. She is an Associate Professor of Pathology at the Cleveland Clinic Lerner College of Medicine and a senior staff in the Department of Laboratory Medicine, section of Hematopathology, in Cleveland Clinic, and laboratory director (CLIA holder) of two Cleveland Clinic family health centers. She has authored/co-authored over 100 peer-reviewed original articles and over 30 educational publications and book chapters, and made numerous presentations in national and international conferences. Dr. Rogers is Vice President of Education for the International Society for Laboratory Hematology and a member of Education Committee in the World Association of Societies of Pathology and Laboratory Medicine. She is a member of editorial board of International Journal of Laboratory Hematology and is an invited reviewer of manuscripts in many respected pathology or hematology journals. Her research interests are in diagnosis of hematologic malignancies, particularly myeloid neoplasm and leukemia, in the bone marrow and cancer cytogenetics. She received the best paper award 2019-2020 in the Department of Laboratory Medicine, Cleveland Clinic with a recent BMPG project, comparison of therapy-related and de novo core binding factor acute myeloid leukemia.

Wayne Tam, MD, PhD
Dr. Tam received his M.D., Ph.D. degrees from the Weill Cornell Medicine Tri-institutional program. He completed a residency in Anatomic Pathology and a Hematopathology fellowship at Weill Cornell, and a research fellowship funded by the Leukemia and Lymphoma Society at the Institution of Cancer Genetics of Columbia University Medical Center. He is currently a Professor of Pathology and Laboratory Medicine and the co-director of the Molecular Hematopathology Laboratory at Weill Cornell. He serves in the Editorial Board for Leukemia and Lymphoma. He is also the co-PI for a R01 grant and the Pathology Core Leader for a SCOR grant funded by Leukemia and Lymphoma. His research interests are focused on the molecular pathogenesis of hematologic malignancies, in particular studies on clonal evolution and biomarker identification for drug resistance and relapse.

Sa A. Wang, MD
Dr. Wang is a professor and the section chief of Clinical Flow Cytometry at the Department of Hematopathology, MD Anderson Cancer Center. Dr. Wang received her doctor degree in medicine and master degree in cancer immunology from Xiangya medical school (Hunan, China) in 1992. Dr. Wang completed a residency training in Anatomic pathology and Clinical Pathology at Yale University School of Medicine, and Hematopathology fellowship at Massachusetts General Hospital. Dr. Wang started her academic career at the University of Massachusetts Medical Center, and moved to MDACC in 2008. Dr. Wang’s clinical expertise and research interest include the use of histology, flow cytometry and molecular genetics for disease diagnosis, classification and risk stratification. Dr. Wang has published over 200 original study articles, >20 invited review articles and 27 book chapters for 7 reference books, and authored the book “Diagnosis of Blood and Bone Marrow Disorders” with Dr. Rob Hasserjian. Dr. Wang is an associate editor for Cytometry B Clinical Cytometry and a council member (2 terms) for the international flow cytometry society. Dr. Wang served as an expert panel member for a combined College of American Pathologist/American Society for Hematology initiative to develop guidelines for the work up of acute leukemia patients led by Dr. Dan Arber. Dr. Wang has obtained multiple industrial funds (>1 million) over her tenure at MDACC to study tumor biomarkers.

Olga K. Weinberg, MD
Dr. Weinberg received her undergraduate degree from the University of Chicago followed by a medical degree from Vanderbilt School of Medicine.  She participated in Howard Hughes medical student fellowship at UCLA and subsequently did her residency training in anatomic pathology and surgical pathology and hematopathology fellowships at Stanford University School of Medicine.  Dr. Weinberg started her academic career at Boston Children’s Hospital and Brigham and Women’s hospital and recently moved to UT Southwestern Medical Center.  She is an associate professor of pathology and a director of fellowship education at UTSW.  Dr. Weinberg has served on numerous education committees including the Society of Hematopathology, USCAP, and International Clinical Cytometry Society, and is currently a member of the executive committee of the Society of Hematopathology.  She has co-organized a national Society of hematopathology workshop on “Molecular Genetics of Hematopoietic Neoplasms” in 2017 that was attended by over 400 hematopathologists.  She has taught and directed numerous education courses including initiating a successful Harvard CME course ‘Current concepts in hematopathology’ in the Boston area and hematopathology short courses held at both USCAP and ASCP.  On a clinical research side, she has a long-standing interest in acute leukemias and myeloid neoplasms and published over 60 papers in well-regarded journals including Modern pathology, American Journal of Hematology and Blood and presented her work at numerous national conferences including USCAP, ASH, and ASCP.  She has served on editorial boards of several well-known journals and co-authored numerous review papers and chapters.